Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.
<h4>Background and aims</h4>Chronic hepatitis C (HCV) is a liver disease affecting over 3 million Americans. Liver biopsy is the gold standard for assessing liver fibrosis and is used as a benchmark for initiating treatment, though it is expensive and carries risks of complications. Fibr...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2011
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/cee6a3f304084a5b9154e1af5ab1e793 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|